Search This Blog

Tuesday, April 9, 2019

Amgen BLA for Evenity approved by FDA

A post to the FDA’s website indicates that Amgen’s Biologic License Application, or BLA, for Evenity was granted approval on April 9
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)